An act to amend Sections 25252 and 108076 of, to add Section 25253.2 to, and to add Chapter 17.5 (commencing with Section 109030) to Part 3 of Division 104 of, the Health and Safety Code, relating to product safety.
Impact
The proposed regulations require the Department of Toxic Substances Control to enforce stringent restrictions on the use of PFAS in consumer products. Manufacturers will need to register by July 1, 2029, providing a statement of compliance, and the department will maintain a list of 'currently unavoidable use' determinations for products that may still legally contain PFAS. This will necessitate significant changes in manufacturing practices and compliance for companies involved in producing products containing these substances.
Summary
Assembly Bill 872, introduced by Assembly Member Blanca Rubio, addresses the growing concerns surrounding perfluoroalkyl and polyfluoroalkyl substances (PFAS), commonly known for their adverse health effects and environmental persistence. The bill aims to enhance product safety by prohibiting the distribution, sale, or offering for sale of certain consumer products that contain intentionally added PFAS, starting January 1, 2028. This legislation is necessary to mitigate the risk posed by these chemicals, which are often found in everyday household items and have been linked to serious health issues.
Sentiment
The sentiment surrounding AB 872 appears to be largely positive among public health advocates and environmental groups who see it as a critical step towards reducing harmful chemical exposure. However, some industry representatives may express concern regarding the practical implications of compliance and impacts on product availability. The balance between environmental health and industry capabilities will be a crucial aspect of the bill’s implementation and public reception.
Contention
Notable points of contention may arise concerning the criteria for determining 'currently unavoidable use' of PFAS. The bill mandates that manufacturers can petition the department for exemptions, which could lead to differing interpretations and challenges in regulation enforcement. Additionally, the potential economic impact on manufacturers reliant on PFAS for product functionality remains an ongoing debate, as adherence to these new regulations will require significant adjustments in production processes.